Written Question · S2W-27176 · Session 2
What the budget of the Scottish Medicines Consortium was in (a) 2001-02, (b) 2002-03, (c) 2003-04, (d) 2004-05 and (e) 2005-06.
The question
To ask the Scottish Executive what the budget of the Scottish Medicines Consortium was in (a) 2001-02, (b) 2002-03, (c) 2003-04, (d) 2004-05 and (e) 2005-06.
The answer
The following table providesthe figures requested:
Year
| Budget
2001-02
| £152,713
2002-03
| £308,120
2003-04
| £338,611
2004-05
| £460,546
2005-06
| £699,580
2006-07
| £883,516
2007-08
| £913,593
Note: all costs up to 2004-05 exclude overheads such asaccommodation, IT, HR and finance functional support, which were absorbed byNHS Quality Improvement Scotland. These support costs are included in thefigures given for 2005-06, 2006-07 and 2007-08.
The Scottish MedicinesConsortium (SMC) reviews and advises NHS Boards on the use of all drugsreceiving licences. The SMC has developed its role over a period of years, andthe number of such drugs has increased considerably. In order to ensure wellinformed and evidence-based recommendations it has been important to havestrong health economic and pharmacy-based input. The SMC also aims to supportthe NHS in anticipating and planning for the introduction of significant newmedications. The SMC is designed to eliminate ‘post code’ prescribing and toensure that all medications it recommends are made available to the people of Scotland tomeet clinical need.
Year
| Budget
2001-02
| £152,713
2002-03
| £308,120
2003-04
| £338,611
2004-05
| £460,546
2005-06
| £699,580
2006-07
| £883,516
2007-08
| £913,593
Note: all costs up to 2004-05 exclude overheads such asaccommodation, IT, HR and finance functional support, which were absorbed byNHS Quality Improvement Scotland. These support costs are included in thefigures given for 2005-06, 2006-07 and 2007-08.
The Scottish MedicinesConsortium (SMC) reviews and advises NHS Boards on the use of all drugsreceiving licences. The SMC has developed its role over a period of years, andthe number of such drugs has increased considerably. In order to ensure wellinformed and evidence-based recommendations it has been important to havestrong health economic and pharmacy-based input. The SMC also aims to supportthe NHS in anticipating and planning for the introduction of significant newmedications. The SMC is designed to eliminate ‘post code’ prescribing and toensure that all medications it recommends are made available to the people of Scotland tomeet clinical need.
In the Official Report
No contribution in the Official Report cites S2W-27176 by reference.